Piper Sandler Comments on Teladoc Health, Inc.’s FY2023 Earnings (NYSE:TDOC)


Share on StockTwits

Teladoc Health, Inc. (NYSE:TDOC) – Stock analysts at Piper Sandler issued their FY2023 earnings per share (EPS) estimates for Teladoc Health in a note issued to investors on Thursday, April 8th. Piper Sandler analyst S. Wieland forecasts that the health services provider will post earnings per share of $0.02 for the year. Piper Sandler has a “Overweight” rating and a $291.00 price objective on the stock.

A number of other equities analysts have also recently commented on TDOC. DA Davidson lifted their target price on shares of Teladoc Health from $260.00 to $275.00 and gave the company a “buy” rating in a report on Wednesday, March 3rd. William Blair reissued an “outperform” rating on shares of Teladoc Health in a research note on Thursday, February 25th. Credit Suisse Group boosted their price objective on shares of Teladoc Health from $296.00 to $300.00 and gave the company an “outperform” rating in a research note on Thursday, March 4th. Jefferies Financial Group dropped their price objective on shares of Teladoc Health from $264.00 to $248.00 and set a “hold” rating on the stock in a research note on Wednesday, March 3rd. Finally, Evercore ISI started coverage on shares of Teladoc Health in a research note on Tuesday, December 22nd. They issued an “in-line” rating and a $215.00 price objective on the stock. Fourteen investment analysts have rated the stock with a hold rating and eighteen have given a buy rating to the stock. Teladoc Health has a consensus rating of “Buy” and a consensus price target of $241.38.

Shares of Teladoc Health stock opened at $189.25 on Monday. The firm’s fifty day simple moving average is $195.10 and its 200-day simple moving average is $215.80. The stock has a market capitalization of $28.90 billion, a price-to-earnings ratio of -132.34 and a beta of 0.30. Teladoc Health has a 12 month low of $147.71 and a 12 month high of $308.00. The company has a debt-to-equity ratio of 0.43, a current ratio of 6.52 and a quick ratio of 6.47.

Teladoc Health (NYSE:TDOC) last announced its earnings results on Wednesday, February 24th. The health services provider reported ($3.07) EPS for the quarter, missing analysts’ consensus estimates of ($0.25) by ($2.82). Teladoc Health had a negative net margin of 12.71% and a negative return on equity of 6.15%.

In other Teladoc Health news, CEO Jason N. Gorevic sold 25,000 shares of the company’s stock in a transaction dated Tuesday, April 6th. The shares were sold at an average price of $182.19, for a total value of $4,554,750.00. Following the transaction, the chief executive officer now directly owns 507,970 shares in the company, valued at approximately $92,547,054.30. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Arnnon Geshuri sold 1,750 shares of the company’s stock in a transaction dated Tuesday, February 16th. The shares were sold at an average price of $298.26, for a total transaction of $521,955.00. Following the completion of the transaction, the insider now owns 102,569 shares in the company, valued at $30,592,229.94. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 674,374 shares of company stock worth $135,744,738. 3.42% of the stock is owned by insiders.

A number of large investors have recently added to or reduced their stakes in the business. Bellecapital International Ltd. acquired a new position in shares of Teladoc Health during the 1st quarter valued at about $361,000. Golden Green Inc. acquired a new position in shares of Teladoc Health during the 1st quarter valued at about $402,000. Royal London Asset Management Ltd. increased its stake in shares of Teladoc Health by 5.4% during the 1st quarter. Royal London Asset Management Ltd. now owns 39,249 shares of the health services provider’s stock valued at $7,134,000 after acquiring an additional 2,028 shares during the last quarter. Winfield Associates Inc. increased its stake in shares of Teladoc Health by 32.8% during the 1st quarter. Winfield Associates Inc. now owns 2,432 shares of the health services provider’s stock valued at $442,000 after acquiring an additional 600 shares during the last quarter. Finally, Harbour Capital Advisors LLC acquired a new position in shares of Teladoc Health during the 1st quarter valued at about $1,385,000. Institutional investors own 51.77% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure.

Featured Article: What is the accumulation/distribution indicator?

Earnings History and Estimates for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.